| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/18/2004 | WO2004022094A1 Allergy vaccines |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004007697A3 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 03/18/2004 | WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 03/18/2004 | WO2003097663A3 Immunogenic, monoclonal antibody comprising at least 2 different epitopes of a tumor-associated antigen |
| 03/18/2004 | WO2003092714A3 Peptide variants of ige constrained by beta-lactam bond |
| 03/18/2004 | WO2003092623A3 Calicheamicin derivative-carrier conjugates |
| 03/18/2004 | WO2003050531A3 Method for displaying loops from immunoglobulin domains in different contexts |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003007874A3 Anti-tumor activity from reptile serum |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002103029A3 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090570A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 03/18/2004 | US20040055027 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 03/18/2004 | US20040055022 Compositions and methods for screening therapeutic agents |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054146 Allergy vaccines |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053865 Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein |
| 03/18/2004 | US20040053848 Antibodies specific for methylated lysines in histones |
| 03/18/2004 | US20040053845 Modified peptides as therapeutic agents |
| 03/18/2004 | US20040053843 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053812 Methods |
| 03/18/2004 | US20040053398 Determination of recombinant glycosylated proteins and peptides in biological fluids |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053372 Comprises prothrombin amino acid sequences for treating thrombosis and blood disorders |
| 03/18/2004 | US20040053371 Comprises immunoglobulins for detection and treatment of alzheimer's disease; immunotherapy |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053365 Humanized GM-CSF antibodies |
| 03/18/2004 | US20040053363 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053359 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053347 Braf35 protein and brca2/braf35 complex and methods of use |
| 03/18/2004 | US20040053346 Agent for detecting cancer's ability to metastasize |
| 03/18/2004 | US20040053343 Antibodies for identifying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 03/18/2004 | US20040053340 Protein arrays |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053325 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |
| 03/18/2004 | US20040053301 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053292 Comprises nucleotide sequences coding polypeptide containing signal peptide sequences for treatment and prevention of psoriasis, asthma, artheriosclerosis, infections, meningitis, pneumonia and multiple sclerosis |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053231 Comprises nucleotide sequences coding cbp/p3000 interacting transativators with ed-rich tails (HCITED) diagnosis, prevention and treatment hypoxia, cardioovascular, inflammatory, cancer and stroke disorders |
| 03/18/2004 | US20040053229 Mammalian protein phosphatases |
| 03/18/2004 | US20040053224 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2004 | US20040052817 A nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052814 Fusion proteins for targeted delivery of antimicrobial peptides |
| 03/18/2004 | US20040052809 Atherosclerosis; apolipoproteins; induce immunology response |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |
| 03/18/2004 | US20040052794 Isolation antibodies; anticancer agents, antitumor agents |
| 03/18/2004 | US20040052792 Administering synergistic mixture of tumor necrosis factor antibodies and interferon antibodies |
| 03/18/2004 | US20040052791 Administering genetic engineered interferon antibody |
| 03/18/2004 | US20040052790 Treatment of schizophrenia |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052788 Cytokine that induces apoptosis |
| 03/18/2004 | US20040052787 Screening for menstruation disorders; measurement nucleic acids or protein |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052785 Synergistic mixtures; antitumor agents |
| 03/18/2004 | US20040052783 Humanized antibodies against CD3 |
| 03/18/2004 | US20040052782 Semaphorin proteins; dendritic cells; gene expression; isolated antibodies; therapy for autoimmune disease |
| 03/18/2004 | US20040052781 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs |
| 03/18/2004 | US20040052780 Immunosuppresants |
| 03/18/2004 | US20040052779 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 03/18/2004 | US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering |
| 03/18/2004 | US20040052773 Production of multi-chain protein from muscle |
| 03/18/2004 | US20040052766 Alzheimer's disease vaccine; induction antibodies, antigens |
| 03/18/2004 | DE10242338A1 New monoclonal antibodies, for identifying and isolating neuronal mesenchymal stem cells, useful in transplantation to regenerate e.g. bone, cartilage or muscle |
| 03/18/2004 | DE10242337A1 New monoclonal antibodies, for identifying and isolating neuronal precursor cells, useful in transplantation for treating neurological injury and disease |
| 03/18/2004 | DE10242146A1 Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen Antibodies for identifying and / or isolating hematopoietic stem cells |
| 03/18/2004 | DE10240569A1 Immunosorbent assay kit for detecting procollagenase 3 (PC3), useful for diagnosis of breast cancer and arthritis, also new monoclonal antibody specific for PC3 |
| 03/18/2004 | CA2801911A1 Antibody against secreted n-terminal peptide of gpc3 present in blood |
| 03/18/2004 | CA2498130A1 Compositions and methods for synthesizing nucleic acids |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497884A1 Therapeutic human anti-il-1r1 monoclonal antibody |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497788A1 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497660A1 Allergy vaccines |
| 03/18/2004 | CA2497628A1 Methods of preventing or treating cell malignancies by administering cd2 antagonists |
| 03/18/2004 | CA2496888A1 Epitope sequences |